Table 1.

Baseline characteristics of patients.

Subgroup	Nab-paclitaxel (n = 79)	Docetaxel (n = 80)	χ2	P
Age (years)
<50	41	43	0.006	0.940
≥50	38	37
Tumor size			0.512	0.474
T1–2	36	42
T3–4	43	38
Grade			0.000	1.000
I–II	39	40
III	40	40
Lymph node status			2.976	0.084
Negative	25	37
Positive	54	43
Hormone receptor			0.051	0.822
Negative	24	22
Positive	55	58
Ki-67			0.276	0.599
≤20%	16	20
>20%	63	60
Clinical stage			0.307	0.580
II	38	43
III	41	37